ADC Therapeutics SA completed a series of strategic transactions in which it:
Entered into a new $175 million senior secured term loan with certain funds of Owl Rock, a division of Blue Owl Capital, Inc. ("Owl Rock"), and funds managed by Oaktree...
Read Story
August 16, 2022, 07:55 AM
|
ADC Therapeutics SA announced the receipt of the $50 million second tranche under its convertible credit facility with Deerfield Partners, L.P. and certain of its affiliates (collectively, Deerfield). Under the terms of the Facility Agreement dated...
Read Story
May 17, 2021, 07:09 AM
|